• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Takeda Pharmaceutical Company Limited (TAK)

American Depository Receipts
Sell: $14.91|Buy: $15.00|Change: 0.07 (0.47%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Address

1-1, Nihonbashi-Honcho 2-Chome
Chuo-ku
Tokyo
JPN
103-8668

Telephone

+81 332782543

Website

https://www.takeda.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Takeda Pharmaceutical Co Ltd Second Quarter Earnings Conference Call for 20262026-10-30T19:00:00
Takeda Pharmaceutical Co Ltd First Quarter Earnings Results for 20262026-07-30T00:00:00
Takeda Pharmaceutical Co Ltd Annual General Meeting for 20262026-06-25T10:00:00
Takeda Pharmaceutical Co Ltd Annual Report for 20252026-06-25T00:00:00
Takeda Pharmaceutical Co Ltd Fourth Quarter Earnings Conference Call for 20252026-05-08T19:00:00
Takeda Pharmaceutical Co Ltd Third Quarter Earnings Conference Call for 20252026-01-30T19:30:00
Takeda Pharmaceutical Co Ltd Third Quarter Earnings Results for 20252026-01-30T00:00:00

Previous key dates

NameKey Date
Takeda Pharmaceutical Co Ltd Second Quarter Earnings Conference Call for 20252025-10-30T19:00:00
Takeda Pharmaceutical Co Ltd Second Quarter Earnings Result for 20252025-10-30T00:00:00
Morgan Stanley Healthcare Conference2025-09-08T15:20:00
Phase 3 data and market opportunity for oveporexton2025-09-08T07:30:00
Takeda Pharmaceutical Co Ltd First Quarter Earnings Results for 20252025-07-30T00:00:00
Takeda Pharmaceutical Co Ltd Annual General Meeting for 20252025-06-25T10:00:00
Takeda Pharmaceutical Co Ltd Annual Report for 20242025-06-25T00:00:00
Jefferies Global Healthcare Conference2025-06-04T09:55:00
Takeda Pharmaceutical Co Ltd Fourth Quarter Earnings Conference Call for 20242025-05-08T19:00:00
Takeda Pharmaceutical Co Ltd Fourth Quarter Earnings Results for 20242025-05-08T00:00:00
Takeda Pharmaceutical Co Ltd Third Quarter Earnings Conference Call for 20242025-01-30T19:30:00
Takeda Pharmaceutical Co Ltd Third Quarter Earnings Result for 20242025-01-30T00:00:00
R&D Day: Focus on Late-Stage Pipeline and Market Opportunity2024-12-13T08:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.